Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $77.11 USD
Change Today +0.88 / 1.15%
Volume 424.9K
LGND On Other Exchanges
As of 8:10 PM 03/31/15 All times are local (Market data is delayed by at least 15 minutes).

Insiders at ligand pharmaceuticals (LGND)

Name (Connections)Board RelationshipsTitleType of Board MemberAge
John Higgins 34 RelationshipsChief Executive Officer and Executive DirectorChief Executive Officer44

Other Board Members on Board*

Name (Connections)Board RelationshipsType of Board MemberPrimary CompanyAge
John Kozarich Ph.D. 50 RelationshipsChairman of the BoardActivX Biosciences, Inc.65
Jason Aryeh 25 RelationshipsMember of the Board of DirectorsJalaa Equities, L.P.46
Todd Davis 19 RelationshipsMember of the Board of DirectorsHealthCare Royalty Partners53
Stephen Sabba M.D. 11 RelationshipsMember of the Board of DirectorsQLT Inc.55
David Knott 26 RelationshipsMember of the Board of DirectorsDorset Management Corporation69
Shalendar Bhasin M.D. 8 RelationshipsMember of Advisory BoardLigand Pharmaceuticals Incorporated--
Sunil Patel 14 RelationshipsMember of the Board of DirectorsOncoMed Pharmaceuticals, Inc.42
John LaMattina Ph.D. 91 RelationshipsMember of the Board of DirectorsTopokine Therapeutics, Inc.64
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LGND:US $77.11 USD +0.88

LGND Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for LGND.
View Industry Companies

Industry Analysis


Industry Average

Valuation LGND Industry Range
Price/Earnings 100.0x
Price/Sales 23.5x
Price/Book 56.7x
Price/Cash Flow 124.5x
TEV/Sales 17.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LIGAND PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at